United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Report 2016

November 2016 | 95 pages | ID: U94431A56ACEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of 23-Valent Pneumococcal Polysaccharide Vaccine

Revenue, means the sales value of 23-Valent Pneumococcal Polysaccharide Vaccine

This report studies sales (consumption) of 23-Valent Pneumococcal Polysaccharide Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• MSD
• Sanofipasteur
• CDIBP

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Single Dose Vial
• Pre-filled Syringe
• Type III

Split by applications, this report focuses on sales, market share and growth rate of 23-Valent Pneumococcal Polysaccharide Vaccine in each application, can be divided into

• For Children (2-10)
• For Person (10-64)
• For The old (≥65)

Contents

United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Report 2016

1 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE OVERVIEW

1.1 Product Overview and Scope of 23-Valent Pneumococcal Polysaccharide Vaccine
1.2 Classification of 23-Valent Pneumococcal Polysaccharide Vaccine
  1.2.1 Single Dose Vial
  1.2.2 Pre-filled Syringe
  1.2.3 Type III
1.3 Application of 23-Valent Pneumococcal Polysaccharide Vaccine
  1.3.1 For Children (2-10)
  1.3.2 For Person (10-64)
  1.3.3 For The old (≥65)
1.4 United States Market Size Sales (Value) and Revenue (Volume) of 23-Valent Pneumococcal Polysaccharide Vaccine (2011-2021)
  1.4.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2011-2021)
  1.4.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2011-2021)

2 UNITED STATES 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE COMPETITION BY MANUFACTURERS

2.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Manufactures (2015 and 2016)
2.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
  2.4.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Rate
  2.4.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type (2011-2016)
3.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2011-2016)
3.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2011-2016)
3.4 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Type (2011-2016)

4 UNITED STATES 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Application (2011-2016)
4.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MANUFACTURERS PROFILES/ANALYSIS

5.1 MSD
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Sanofipasteur
  5.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 CDIBP
  5.3.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview

6 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MANUFACTURING COST ANALYSIS

6.1 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET FORECAST (2016-2021)

10.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue Forecast (2016-2021)
10.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2016-2021)
10.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2016-2021)
10.4 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Table Classification of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure United States Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type in 2015
Figure Single Dose Vial Picture
Figure Pre-filled Syringe Picture
Table Application of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure United States Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in 2015
Figure For Children (2-10) Examples
Figure For Person (10-64) Examples
Figure For The old (≥65) Examples
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2011-2021)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2011-2021)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers
Figure 2016 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers
Table 2016 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers
Table United States Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price of Key Manufacturers in 2015
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 3 Manufacturers
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 5 Manufacturers
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2011-2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2011-2016)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2015
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2011-2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2011-2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2011-2016)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Type (2011-2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2011-2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2011-2016)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2015
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2011-2016)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2011-2016)
Table MSD Basic Information List
Table MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share (2011-2016)
Table Sanofipasteur Basic Information List
Table Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share (2011-2016)
Table CDIBP Basic Information List
Table CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
Table Raw Materials Sources of 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in 2015
Table Major Buyers of 23-Valent Pneumococcal Polysaccharide Vaccine
Table Distributors/Traders List
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Production and Growth Rate Forecast (2016-2021)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Production Forecast by Type (2016-2021)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Application (2016-2021)